A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease

Brain

Volumn 128, Issue 10, 2005, Pages 2272-2280

  Halliday, Glenda M ^a,b   Macdonald, Virginia ^a   Henderson, Jasmine M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

synuclein; Motor cortex; Stereology; Tau; Thalamus

Indexed keywords

ALPHA SYNUCLEIN; TAU PROTEIN; UBIQUITIN;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BRAIN CORTEX; BRAIN CORTEX ATROPHY; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTERNEURON; LEWY BODY; MALE; MOTOR CORTEX; NERVE PROJECTION; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; PATHOGENESIS; PREMOTOR CORTEX; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RETROSPECTIVE STUDY; SEROLOGY; THALAMOCORTICAL TRACT; THALAMUS POSTERIOR NUCLEUS;

AGED; ALPHA-SYNUCLEIN; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; LEWY BODIES; MALE; MOTOR CORTEX; MOTOR NEURONS; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE; PROSPECTIVE STUDIES; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS; THALAMUS; UBIQUITIN; VENTRAL THALAMIC NUCLEI;

EID: 26044469856     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awh596     Document Type: Article

References (76)

1. Amano N, Nagatomo H, Yokoi S, Yagishita S, Saitoh A, Mizutani T. The thalamic changes in progressive supranuclear palsy. No To Shinkei 1992; 44: 421-8.
2. Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain 1998; 121: 1195-212.
3. Bigio EH, Vono MB, Satumtira S, Adamson J, Sontag E, Hynan LS, et al. Cortical synapse loss in progressive supranuclear palsy. J Neuropathol Exp Neurol 2001; 60: 403-10.
4. Brown P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord 2003; 18: 357-63.
5. Brown P, Oliviero A, Mazzone P, Insola A, Tonali P, Di Lazzaro V. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci 2001; 21: 1033-8.
6. Buhmann C, Glauche V, Stürenburg HJ, Oechsner M, Weiller C, Büchel C. Pharmacologically modulated fMRI - cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 2003; 126: 451-61.
7. Cordato NJ, Halliday GM, Harding AJ, Hely MA, Morris JGL. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol 2000; 47: 718-28.
8. Cunnington R, Egan G, O'Sullivan J, Hughes A, Bradshaw J, Colebatch J. Motor imagery in Parkinson's disease: a PET study. Mov Disord 2001; 16: 849-57.
9. Devos D, Labyt E, Derambure P, Bourriez JL, Cassim F, Reyns N, et al. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease. Brain 2004; 127: 408-19.
10. Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999; 246 (Suppl 2): II6-15.
11. Dum RP, Strick PL. Motor areas in the frontal lobe of the primate. Physiol Behav 2002; 77: 677-82.
12. Foffani G, Priori A, Egidi M, Rampini P, Tamma F, Caputo E, et al. 300-Hz subthalamic oscillations in Parkinson's disease. Brain 2003; 126: 2153-63.
13. Fukuda M, Mentis M, Ma Y, Antonini A, Lang A, Lozano A, et al. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Brain 2001; 124: 1601-9.
14. Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Berger B. Alterations in dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol 1991; 30: 365-74.
15. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol 1999; 56: 33-9.
16. Geyer S, Matelli M, Luppino G, Zilles K. Functional neuroanatomy of the primate isocortical motor system. Anat Embryol (Berl) 2000; 202: 443-74.
17. Goldberg JA, Boraud T, Maraton S, Haber SN, Vaadia E, Bergman H. Enhanced synchrony among primary motor cortex neurons in the MPTP primate model of Parkinson's disease. J Neurosci 2002; 22: 4639-53.
18. Goldberg JA, Rokni U, Boraud T, Vaadia E, Bergman H. Spike synchronization in the cortex-basal ganglia networks of Parkinsonian primates reflects global dynamics of the local field potentials. J Neurosci 2004; 24: 6003-10.
19. Guillery RW, Sherman SM. Thalamic relay functions and their role in corticocortical communication: generalizations from the visual system. Neuron 2002; 33: 163-75.
20. Haber SN, McFarland NR. The place of the thalamus in frontal cortical-basal ganglia circuits. Neuroscientist 2001; 7: 315-24.
21. Hamani C, Saint-Cyr JA, Fraser J, Kaplitt M, Lozano AM. The subthalamic nucleus in the context of movement disorders. Brain 2003; 127: 4-20.
22. Hanihara T, Amano N, Takahashi T, Nagatomo H, Yagashita S. Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy. Neuropathol Appl Neurobiol 1995; 21: 319-26.
23. Hardman CD, Halliday GM. The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy. Mov Disord 1999a; 14: 626-33.
24. Hardman CD, Halliday GM. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease. Exp Neurol 1999b; 158: 135-42.
25. Hardman CD, McRitchie DA, Halliday GM, Cartwright HR, Morris JGL. The substantia nigra pars reticulata in Parkinson's disease. Neurodegeneration 1996; 5: 49-55.
26. Hardman CD, Halliday GM, McRitchie DA, Cartwright HR, Morris JGL. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata. Exp Neurol 1997a; 144: 183-92.
27. Hardman CD, Halliday GM, McRitchie DA, Morris JG. The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy. J Neuropathol Exp Neurol 1997b; 56: 132-42.
28. Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 2003; 23: 1916-23.
29. Haslinger B, Erhard P, Kampfe N, Boecker H, Rummeny E, Schwaiger M, et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001; 124: 558-70.
30. Hauw J, Daniel S, Dickson D, Horoupian D, Jellinger K, Lantos P, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015-19.
31. Hauw J-J, Verny M, Delaere P, Cervera P, He Y, Duyckaerts C. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy: basic differences with Alzheimer's disease and aging. Neurosci Lett 1990; 119: 182-6.
32. Henderson JM, Carpenter K, Cartwright H, Halliday GM. Degeneration of the thalamic caudal intralaminar nuclei in Parkinson's disease. Ann Neurol 2000a; 47: 345-52.
33. Henderson JM, Carpenter K, Cartwright H, Halliday GM. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000b; 123: 1410-21.
34. Hirai T, Jones E. A new parcellation of the human thalamus on the basis of histochemical staining. Brain Res Rev 1989; 14: 1-34.
35. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-42.
36. Jones EG. The thalamus. New York: Plenum Press; 1985.
37. Jones EG. Viewpoint: the core and matrix of thalamic organization. Neuroscience 1998; 85: 331-45.
38. Jones EG. The thalamic matrix and thalamocortical synchrony. Trends Neurosci 2001; 24: 595-601.
39. Kassubek J, Juengling FD, Hellwig B, Knauff M, Spreer J, Lücking CH. Hypermetabolism in the ventrolateral thalamus in unilateral Parkinsonian resting tremor: a positron emission tomography study. Neurosci Lett 2001; 304: 17-20.
40. Kassubek J, Juengling FD, Hellwig B, Spreer J, Lücking CH. Thalamic grey matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci Lett 2002; 323: 29-32.
41. Kofler M, Muller J, Reggiani L, Wenning GK. Somatosensory evoked potentials in progressive supranuclear palsy. J Neurol Sci 2000; 179: 85-91.
42. Krack P, Dostrovsky J, Ilinsky I, Kultas-Ilinsky K, Lenz F, Lozano A, et al. Surgery of the motor thalamus: problems with the present nomenclatures. Mov Disord 2002; 17 (Suppl 3): S2-8.
43. Kuhn AA, Grosse P, Holtz K, Brown P, Meyer BU, Kupsch A. Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes. Clin Neurophysiol 2004; 115: 1786-95.
44. Lewis GN, Byblow WD. Altered sensorimotor integration in Parkinson's disease. Brain 2002; 125: 2089-99.
45. Li F, Iseki E, Odawara T, Kosaka K, Yagishita S, Amano N. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease. J Neurol Sci 1998; 159: 73-81.
46. Litvan I. The clinical and pathologic hallmarks of progressive supranuclear palsy. Curr Opin Neurol 1997; 10: 346-50.
47. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996; 55: 97-105.
48. 1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients. Neurol Sci 2001; 22: 69-70.
49. Macchi G, Jones EG. Toward an agreement on terminology of nuclear and subnuclear divisions of the motor thalamus. J Neurosurg 1997; 86: 670-85.
50. Macdonald V, Halliday GM. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease. Mov Disord 2002; 17: 1166-73.
51. McFarland NR, Haber SN. Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas. J Neurosci 2002; 22: 8117-32.
52. Naidich TP, Hof PR, Yousry TA, Yousry I. The motor cortex: anatomic substrates of function. Neuroimaging Clin N Am 2001; 11: 171-93, vii-viii.
53. Nishimura T, Ikeda K, Akiyama H, Kondo H, Kato M, Li F, et al. Immunohistochemical investigation of tau-positive structures in the cerebral cortex of patients with progressive supranuclear palsy. Neurosci Lett 1995; 201: 123-6.
54. Okuda B, Tachibana H, Kawabata K, Takeda M, Sugita M. Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. Alzheimer Dis Assoc Disord 2000; 14: 46-52.
55. Pagni CA, Zeme S, Zenga F. Further experimentation with extradural motor cortex stimulation for treatment of advanced Parkinson's disease. Report of 3 new cases. J Neurosurg Sci 2003; 47: 189-93.
56. Percheron G, Francois C, Talbi B, Yelnik J, Fenelon G. The primate motor thalamus. Brain Res Rev 1996; 22: 93-181.
57. Picard N, Strick PL. Imaging the premotor areas. Curr Opin Neurobiol 2001; 11: 663-72.
58. Piccini P, de Yebenez J, Lees AJ, Ceravolo R, Turjanski N, Pramstaller P, et al. Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography. Arch Neurol 2001; 58: 1846-51.
59. Rouiller EM, Welker E. A comparative analysis of the morphology of corticothalamic projections in mammals. Brain Res Bull 2000; 53: 727-41.
60. Rub U, Del Tredici K, Schultz C, Ghebremedhin E, de Vos RA, Jansen Steur E, et al. Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology. Neurobiol Aging 2002; 23: 245-54.
61. Sabatini U, Boulanouar K, Martin F, Carel C, Colonese C, Bozzao L, et al. Cortical motor reorganisation in akinetic patients with Parkinson's disease: A functional MRI study. Brain 2000; 123: 394-403.
62. Salmon E, Van der Linden M, Franck G. Anterior cingulate and motor network metabolic impairment in progressive supranuclear palsy. Neuroimage 1997; 5: 173-8.
63. Schell GR, Strick PL. The origin of thalamic inputs to the arcuate premotor and supplementary motor areas. J Neurosci 1984; 4: 539-60.
64. Sherman SM, Guillery RW. On the actions that one nerve cell can have on another: distinguishing 'drivers' from 'modulators'. Proc Natl Acad Sci USA 1998; 95: 7121-6.
65. Sherman SM, Guillery RW. The role of the thalamus in the flow of information to the cortex. Philos Trans R Soc Lond B Biol Sci 2002; 357: 1695-708.
66. Tamburin S, Fiaschi A, Idone D, Lochner P, Manganotti P, Zanette G. Abnormal sensorimotor integration is related to disease severity in Parkinson's disease: a TMS study. Mov Disord 2003; 18: 1316-23.
67. Thobois S, Dominey P, Decety J, Pollak P, Gregoire M, Le Bars D, et al. Motor imagery in normal subjects and in asymmetrical Parkinson's disease: a PET study. Neurology 2000; 55: 996-1002.
68. Tsuboi Y, Slowinski J, Josephs KA, Honer WG, Wszolek ZK, Dickson DW. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2003; 60: 1766-9.
69. Vaillancourt DE, Prodoehl J, Verhagen ML, Bakay RA, Corcos DM. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease. Brain 2004; 127: 491-504.
70. Vermesch P, Robitaille Y, Bernier L, Wattez A, Gauvreau D, Delacourte A. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol 1994; 87: 572-7.
71. Verny M, Duyckaerts C, Agid Y, Hauw JJ. The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain 1996a; 119: 1123-36.
72. Verny M, Jellinger KA, Hauw J-J, Bancher C, Litvan I, Agid Y. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol 1996b; 91: 427-31.
73. Wakabayashi K, Mori F, Oyama Y, Kurihara A, Kamada M, Yoshimoto M, et al. Lewy bodies in Betz cells of the motor cortex in a patient with Parkinson's disease. Acta Neuropathol 2002; 105: 189-92.
74. Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, et al. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord 1999; 14: 947-50.
75. Williams D, Tijssen M, van Bruggen G, Bosch A, Insola A, Di Lazzaro V, et al. Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex. Brain 2002; 125: 1558-69.
76. Xuereb JH, Perry RH, Candy JM, Perry EK, Marshall E, Bonham JR. Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain 1991; 114: 1363-79.